MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TGTX has $1,063,253K in assets. $415,233K in debts. $79,148K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
410.23%
Quick Ratio
328.55%
Cash Ratio
51.48%
Debt to Asset Ratio
39.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Deferred tax assets
    • Accounts receivable, net
    • Inventory
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Loan payable non-current
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
79,148
Short-term investment securities
62,822
Accounts receivable, net
305,628
Inventory
125,586
Other current assets
57,580
Total current assets
630,764
Restricted cash
1,342
Long-term investment securities
59,136
Right of use assets
6,278
Deferred tax assets
348,000
Long-term inventory
15,689
Other noncurrent assets
2,044
Total assets
1,063,253
Accounts payable and accrued expenses
107,508
Other current liabilities
2,124
Lease liability current portion
1,044
Deferred revenue - current portion
21,234
Accrued compensation
21,850
Total current liabilities
153,760
Deferred revenue, non-current portion
8,807
Loan payable non-current
245,645
Lease liability non-current
7,021
Total liabilities
415,233
Common stock, 0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 158,849,596 and 156,204,159 shares issued, 155,305,953 and 155,836,256 shares outstanding at december 31, 2025 and december 31, 2024, respectively)
159
Additional paid-in capital
1,830,110
Treasury stock, at cost, 3,543,643 and 367,903 shares at december 31, 2025 and december 31, 2024
100,234
Accumulated deficit
-1,082,015
Total stockholders equity
648,020
Total liabilities and stockholders equity
1,063,253
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$305,628K Inventory$125,586K Cash and cashequivalents$79,148K Short-term investmentsecurities$62,822K Other current assets$57,580K Total current assets$630,764K Deferred tax assets$348,000K Long-term investmentsecurities$59,136K Long-term inventory$15,689K Right of use assets$6,278K Other noncurrentassets$2,044K Restricted cash$1,342K Total assets$1,063,253K Total liabilities andstockholders equity$1,063,253K Total stockholdersequity$648,020K Total liabilities$415,233K Accumulated deficit-$1,082,015K Treasury stock, at cost,3,543,643 and 367,903...$100,234K Additional paid-in capital$1,830,110K Loan payable non-current$245,645K Total currentliabilities$153,760K Deferred revenue,non-current portion$8,807K Lease liability non-current$7,021K Common stock, 0.001 parvalue per share...$159K Accounts payable andaccrued expenses$107,508K Accrued compensation$21,850K Deferred revenue -current portion$21,234K Other currentliabilities$2,124K Lease liability current portion$1,044K

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)